Gilder Gagnon Howe & CO LLC Atai Life Sciences N.V. Transaction History

Gilder Gagnon Howe & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.03 - $5.32 $780,594 - $1.37 Million	-257,622 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.66 - $7.66 $6,607 - $10,861	-1,418 Reduced 0.55%	257,622 $1.31 Million
Q4 2021 Feb 14, 2022	SELL	$6.82 - $17.8 $1.24 Million - $3.24 Million	-182,162 Reduced 41.29%	259,040 $1.98 Million
Q3 2021 Nov 15, 2021	BUY	$13.62 - $19.48 $52,150 - $74,588	3,829 Added 0.88%	441,202 $6.53 Million
Q2 2021 Aug 16, 2021	BUY	$16.94 - $19.89 $7.41 Million - $8.7 Million	437,373 New	437,373 $8.09 Million

12.8M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $189M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.